On Thursday night, the NBA announced the remainder of its All-Star game rosters after they revealed the starters a week prior. Mavs fans hoped that star guard Kyrie Irving would be included, but were ...
Cancer research – which relies heavily on NIH funding – was suddenly uncertain, sparking fears of job losses, delayed ...
Doncic not making the cut is understandable: the Mavs star has been out for a month after suffering a calf injury during their Christmas Day game. Irving's omission, though, has raised some eyebrows ...
Mark Cuban's investment advice for the average person isn't about getting rich quick or high-flying stocks. It's about discipline, smart spending, and patient investment.
The pitch was so convincing that it made history on Shark Tank, bringing all five Sharks – Cuban, Kevin O'Leary, Daymond John ...
Setting his children up to find their own success, not just benefit from his, is a key motivator in Cuban’s parenting style.
Mark Cuban has seen it all during his long tenure on Shark Tank. With more than a decade of deals under his belt, the billionaire investor has backed everything from game-changing tech startups to ...
Mark Cuban has expressed earlier that he isn't a fan of meme coins. Gage Skidmore/Flickr.com On 20th January, Billionaire investor and Shark Tank star Mark Cuban posted on X.com, formerly Twitter ...
There’s passionate debate about how to solve America’s ongoing housing crisis, much of which revolves around mortgage rates, zoning issues, immigration and construction. However, billionaire ...
Last year in the wake of a Secret Service probe into Elon Musk‘s online remarks, entrepreneur Mark Cuban came forward to defend Musk’s online antics, despite acknowledging them as “kind of ...
Cuban is a vehement investor whose portfolio includes diverse companies, including the Dallas Mavericks NBA franchise, Magnolia Pictures, and copious other organisations.
Billionaire and celebrity entrepreneur Mark Cuban has revealed his latest move to tackle the cost of medicines in the US, agreeing a deal to make a low-cost biosimilar version of AbbVie’s ...